Ballard DJ Retrospective studies of left atrial thrombus: does misclassification impair their clinical utility? J Gen Intern Med. 1991 Mar-Apr;6(2):177-8.
Beard CM, Fuster V, Annegers JF Reproductive history in women with coronary heart disease. A case-control study. Am J Epidemiol. 1984 Jul;120(1):108-14.
Beard CM, Fuster V, Elveback LR Daily and seasonal variation in sudden cardiac death, Rochester, Minnesota, 1950-1975. Mayo Clin Proc. 1982 Nov;57(11):704-6.
Beard CM, Kottke TE, Annegers JF, Ballard DJ The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982. Mayo Clin Proc. 1989 Dec;64(12):1471-80.
Beard CM, Orencia A, Kottke T, Ballard DJ Body mass index and the initial manifestation of coronary heart disease in women aged 40-59 years. Int J Epidemiol. 1992 Aug;21(4):656-64. Erratum in: Int J Epidemiol 1992 Oct;21(5):1037.
Connolly DC, Elveback LR, Oxman HA Coronary heart disease in residents of Rochester, Minnesota, 1950-1975. III. Effect of hypertension and its treatment on survival of patients with coronary artery disease. Mayo Clin Proc. 1983 Apr;58(4):249-54.
Connolly DC, Elveback LR, Oxman HA Coronary heart disease in residents of Rochester, Minnesota. IV. Prognostic value of the resting electrocardiogram at the time of initial diagnosis of angina pectoris. Mayo Clin Proc. 1984 Apr;59(4):247-50.
Connolly DC, Elveback LR Coronary heart disease in residents of Rochester, Minnesota. VI. Hospital and posthospital course of patients with transmural and subendocardial myocardial infarction. Mayo Clin Proc. 1985 Jun;60(6):375-81.
Elveback LR, Connolly DC, Kurland LT Coronary heart disease in residents of Rochester, Minnesota. II. Mortality, incidence, and survivorship, 1950-1975. Mayo Clin Proc. 1981 Nov;56(11):665-72.
Elveback LR, Connolly DC, Melton LJ 3rd Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982. Mayo Clin Proc. 1986 Nov;61(11):896-900.
Elveback LR, Connolly DC Coronary heart disease in residents of Rochester, Minnesota. V. Prognosis of patients with coronary heart disease based on initial manifestation. Mayo Clin Proc. 1985 May;60(5):305-11.
Gersh BJ, Rihal CS, Rooke TW, Ballard DJ Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol. 1991 Jul;18(1):203-14. Review.
Hallett JW Jr, Naessens JM, Ballard DJ Early and late outcome of surgical repair for small abdominal aortic aneurysms: a population-based analysis. J Vasc Surg. 1993 Oct;18(4):684-91.
Iqbal A, Gibbons RJ, Zinsmeister AR, Mock MB, Ballard DJ Prognostic value of exercise radionuclide angiography in a population-based cohort of patients with known or suspected coronary artery disease. Am J Cardiol. 1994 Jul 15;74(2):119-24.
Kottke TE, Brekke ML Cholesterol policy: what should we do? How should we decide? J Clin Epidemiol. 1990;43(10):1023-7.
Kottke TE, Daida H Evaluating the effectiveness of dyslipidemia control strategies. Atherosclerosis. 1994 Aug;108 Suppl:S127-35.
Kottke TE, Gatewood LC, Park HA Using serum cholesterol to identify high risk and stimulate behavior change: will it work? Ann Med. 1989 Jun;21(3):181-7.
Kottke TE, Solberg LI, Brekke ML Initiation and maintenance of patient behavioral change: what is the role of the physician? J Gen Intern Med. 1990 Sep-Oct;5(5 Suppl):S62-7.
Kottke TE Clinical preventive services: how should we define the indications? Mayo Clin Proc. 1990 Jun;65(6):899-902.
Kottke TE The "Intervention Index": insufficient information. J Clin Epidemiol. 1992 Jan;45(1):17-9.
Leibson CL, Ballard DJ, Whisnant JP, Melton LJ 3rd The compression of morbidity hypothesis: promise and pitfalls of using record-linked data bases to assess secular trends in morbidity and mortality. Milbank Q. 1992;70(1):127-54. Review.
Orencia A, Bailey K, Yawn BP, Kottke TE Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death. JAMA. 1993 May 12;269(18):2392-7.
Rihal CS, Gersh BJ, Whisnant JP, Rooke TW, Sundt TM Jr, O'Fallon WM, Ballard DJ Influence of coronary heart disease on morbidity and mortality after carotid endarterectomy: a population-based study in Olmsted County, Minnesota (1970-1988). J Am Coll Cardiol. 1992 May;19(6):1254-60. Erratum in: J Am Coll Cardiol 1992 Nov 1;20(5):1304.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
